ducovest

VIOV:NYE-Vanguard S&P Small-Cap 600 Value Index Fund ETF Shares (USD)

ETF | Small Value |

Last Closing

USD 96.3

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.05M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

N/A

 USD 31.10B
IJS iShares S&P Small-Cap 600 Valu..

N/A

 USD 7.03B
DES WisdomTree U.S. SmallCap Divid..

N/A

 USD 2.01B
XSVM Invesco S&P SmallCap Value wit..

N/A

 USD 0.86B
XSLV Invesco S&P SmallCap Low Volat..

N/A

 USD 0.33B
RZV Invesco S&P SmallCap 600® Pur..

N/A

 N/A
JKL iShares Morningstar Small-Cap ..

N/A

 N/A
SLYV SPDR® S&P 600 Small Cap Value..

N/A

 N/A
FDM First Trust Dow Jones Select M..

N/A

 N/A
PXSV Invesco S&P SmallCap Value wit..

N/A

 N/A

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.81% 55% F 56% F
Dividend Return 1.33% 55% F 25% F
Total Return 10.15% 55% F 50% F
Trailing 12 Months  
Capital Gain 22.75% 54% F 67% D+
Dividend Return 2.73% 92% A 38% F
Total Return 25.48% 69% C- 66% D+
Trailing 5 Years  
Capital Gain 43.01% 38% F 68% D+
Dividend Return 10.89% 58% F 33% F
Total Return 53.90% 38% F 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 12.81% 54% F 71% C-
Dividend Return 14.51% 54% F 71% C-
Total Return 1.70% 85% B 42% F
Risk Return Profile  
Volatility (Standard Deviation) 32.30% 54% F 33% F
Risk Adjusted Return 44.92% 54% F 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike